Akt activation confers an inferior survival in patients with activated B-cell subtype of diffuse large B-cell lymphoma: A report from the International DLBCL Rituximab-CHOP Consortium program Meeting Abstract
| Authors: | Shen, Q.; Xu-Monette, Z. Y.; Manyam, G.; Visco, C.; Tzankov, A.; Cao, X.; Deng, L. J.; Montes-Moreno, S.; Dybkaer, K.; Chiu, A.; Orazi, A.; Zu, Y. L.; Bhagat, G.; Richards, K. L.; Hsi, E. D.; Choi, W.; Van Krieken, J. H. J. M.; Huh, J.; Ponzoni, M.; Ferreri, A. J. M.; Farnen, J. P.; Moller, M. B.; Winter, J. N.; Piris, M. A. A.; Medeiros, L. J.; Young, K. H. |
| Abstract Title: | Akt activation confers an inferior survival in patients with activated B-cell subtype of diffuse large B-cell lymphoma: A report from the International DLBCL Rituximab-CHOP Consortium program |
| Meeting Title: | 56th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 124 |
| Issue: | 21 |
| Meeting Dates: | 2014 Dec 6-9 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2014-12-06 |
| Language: | English |
| ACCESSION: | WOS:000349243501136 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V124.21.143.143 |
| Notes: | Meeting Abstract: 143 -- 56th Annual Meeting of the American-Society-of-Hematology -- DEC 06-09, 2014 -- San Francisco, CA -- Source: Wos |
